Hyqvia Side Effects

Generic name: hyaluronidase / immune globulin

Medically reviewed by Drugs.com. Last updated on Jan 22, 2024.

Note: This document provides detailed information about Hyqvia Side Effects associated with hyaluronidase / immune globulin. Some dosage forms listed on this page may not apply specifically to the brand name Hyqvia.

Applies to hyaluronidase / immune globulin: subcutaneous solution.

Important warnings This medicine can cause some serious health issues

Subcutaneous route (kit)

Warning: Thrombosis. Thrombosis may occur with immune globulin products, including immune globulin/recombinant human hyaluronidase.

Risk factors may include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity and cardiovascular risk factors.

Thrombosis may occur in the absence of known risk factors.For patients at risk of thrombosis, administer immune globulin/recombinant human hyaluronidase at the minimum dose and infusion rate practicable.

Ensure adequate hydration in patients before administration.Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity.

Serious side effects of Hyqvia

Along with its needed effects, hyaluronidase / immune globulin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hyaluronidase / immune globulin:

More common

• fever

Other side effects of Hyqvia

Some side effects of hyaluronidase / immune globulin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• headache
• nausea
• red streaks on the skin
• swelling, tenderness, or pain at the injection site
• unusual tiredness or weakness
• vomiting

Less common

• itching, redness, swelling, discomfort, or pain at the injection site

For healthcare professionals

Applies to hyaluronidase / immune globulin: subcutaneous solution.

General

The most common adverse events were local reactions, headache, antibody formation against recombinant human hyaluronidase (rHuPH20), fatigue, nausea, pyrexia, and vomiting.^[Ref]

Local

• Very common (10% or more): Local reaction (51.9%)
• Frequency not reported: Local pain and swelling, discomfort/pain, erythema, pruritus^[Ref]

Nervous system

• Very common (10% or more): Headache (21%), fatigue (11.1%)
• Postmarketing reports: Transient ischemic attack, tremor, burning sensation, cerebrovascular accident, coma, seizures, loss of consciousness^[Ref]

Immunologic

• Very common (10% or more): Antibodies to recombinant human hyaluronidase (18%)^[Ref]

Other

• Very common (10% or more): Systemic adverse reaction (67.9%)
• Common (1% to 10%): Pyrexia
• Frequency not reported: Fever, back injury, transient swelling from abdominal infusion site to genitalia
• Postmarketing reports: Edema, rigors^[Ref]

Gastrointestinal

• Common (1% to 10%): Nausea, vomiting
• Postmarketing reports: Abdominal pain^[Ref]

Hematologic

• Frequency not reported: Acute intravascular hemolysis
• Postmarketing reports: Leukopenia, pancytopenia^[Ref]

Renal

• Frequency not reported: Acute renal dysfunction/failure^[Ref]

Cardiovascular

• Postmarketing reports: Hypotension, hypertension, myocardial infarction, chest pain, cardiac arrest, vascular collapse^[Ref]

Respiratory

• Postmarketing reports: Pulmonary edema, dyspnea, oxygen saturation decreased, cyanosis, hypoxemia, bronchospasm, apnea, acute respiratory distress syndrome (ARDS)^[Ref]

Dermatologic

• Postmarketing reports: Hyperhidrosis, allergic dermatitis, bullous dermatitis, epidermolysis, erythema multiforme, Stevens-Johnson Syndrome^[Ref]

Hepatic

• Postmarketing reports: Hepatic dysfunction^[Ref]

Psychiatric

• Postmarketing reports: Anxiety, insomnia^[Ref]

Musculoskeletal

• Postmarketing reports: Back pain^[Ref]

Further information

Hyqvia side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer